Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4649689
Max Phase: Preclinical
Molecular Formula: C37H53N3O13
Molecular Weight: 747.84
Molecule Type: Unknown
Associated Items:
ID: ALA4649689
Max Phase: Preclinical
Molecular Formula: C37H53N3O13
Molecular Weight: 747.84
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O
Standard InChI: InChI=1S/C37H53N3O13/c1-8-12-39-28-22-13-18(2)14-26(50-7)34(52-36-32(46)31(45)30(44)27(17-41)51-36)21(5)15-20(4)33(53-37(38)48)25(49-6)11-9-10-19(3)35(47)40-23(29(22)43)16-24(28)42/h8-11,15-16,18,21,25-27,30-34,36,39,41,44-46H,1,12-14,17H2,2-7H3,(H2,38,48)(H,40,47)/b11-9-,19-10+,20-15+/t18-,21+,25+,26+,27-,30-,31+,32-,33+,34-,36+/m1/s1
Standard InChI Key: HFXJMPSEDMJGBM-KQOVDUKSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 747.84 | Molecular Weight (Monoisotopic): 747.3578 | AlogP: 0.36 | #Rotatable Bonds: 9 |
Polar Surface Area: 245.43 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.11 | CX Basic pKa: | CX LogP: 0.79 | CX LogD: 0.79 |
Aromatic Rings: 0 | Heavy Atoms: 53 | QED Weighted: 0.12 | Np Likeness Score: 2.42 |
1. Li HM, Li B, Sun X, Ma H, Zhu M, Dai Y, Ma T, Li Y, Hong YS, Wu CZ.. (2020) Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents., 30 (15): [PMID:32527461] [10.1016/j.bmcl.2020.127282] |
Source(1):